Emcure Pharma IPO: Key Details to Know
Offer Details:
IPO Opens: July 3, 2024
IPO Closes: July 5, 2024
Issue Size: ₹1,952.03 crore, comprising:
- Fresh issue: ₹800 crore
- Offer for sale (OFS): ₹1,152.03 crore
Lot Size and Price Band:
Lot Size: 14 shares
Price Band: ₹960 – ₹1,008 per share
Reservation and Allocation:
- 50% of the IPO reserved for Qualified Institutional Buyers (QIBs)
- 35% reserved for retail investors
- 15% reserved for non-institutional investors
Company Profile:
- Engaged in developing, manufacturing, and marketing pharmaceutical products
- Focus on therapeutic areas like oncology, cardiovascular, and HIV
- Strong presence in European and Canadian markets
- 13th largest pharmaceutical company in India by domestic sales
Financials:
- Revenue for FY24: ₹6,658 crore
- Profit after tax (PAT) for FY24: ₹527.58 crore
- Strong net worth growth of 18% in FY24
Use of Proceeds:
- Repayment of borrowings: ₹600 crore
- General corporate purposes: ₹200 crore
Key Considerations:
- Strong market position in several therapeutic areas
- Experienced management team and supportive investors like Bain Capital
- Subject to extensive government regulations
- Competition from established pharmaceutical companies
- Negative cash and cash equivalents in recent years
Brokerage Firm IPO Review:
Reviews not yet available.
IPO Timeline:
Anchor Investor Offer: July 2, 2024
Subscription Period: July 3-5, 2024
Allotment Date: July 8, 2024
Listing Date: July 10, 2024
Disclaimer:
This article is for informational purposes only and should not be construed as investment advice. Investors should consult with registered investment advisors or other qualified professionals before making any investment decisions.